Boosting medical innovations
As there was a lack of external motivation before, many of us were surprised by the number of operational innovations in both the market and the health system driven by the coronavirus pandemic. Our current post-covid situation confirms that each crisis has a potential to start functional changes of the system from which we can profit even after the crisis subsides. The most common question is: Why haven’t we done this before?
E-recipes and video consultations
Many European hospitals and specialists introduced some system notifying patients to avoid tiring unnecessary waiting or gathering people. Both to prevent spreading of the illness and to relieve overworked doctors and other clinicians on the frontline. One of the most useful
tools is undoubtedly the system of e-receipts. During the pandemic it became more common to solve certain health problems remotely, through video consultations or by e-mail. And some doctors’ offices started offering such service to the patients from now on. Elderly
patients can take the advantage of home-delivered prescription drugs or safety devices like smart watch bands for seniors.
Fewer doctor visits and early detection of the problems
Using new technologies on a daily basis have resulted in improving patients´ experience. Driven by the pandemic, many remote diagnose and symptom check apps were programmed. Their key contribution is the ability to take timely action based on early warning systems that provide nearly real-time, actionable information on emerging diseases. We have revealed the potential of shared data (covid apps, self-check apps) which are based on real world and real time. This pointed out the value of collaborative working – that the ability to collect, share and analyze a wide range of data is essential for treatment development. Several biotech and pharma industries are working towards a vaccine against Covid-19 and some of them are even in preclinical testing of their own vaccines.
Helping to control the pandemic
According to the recent research, the fast transmission of Covid-19 has revealed weaknesses in current monitoring practices in Switzerland, which heavily rely on decentralized reporting of positive laboratory tests. Wide range of tools aim to contribute to controlling the current epidemic or mitigating its effects. They combine epidemiological data and analysis, outlining the mechanisms through which they can support the fight against COVID-19.
These applications can be seen both as future challenges and opportunities for healthcare – we will see rapid advancement in this area, which will form a pressure for defining new guidelines and standards of healthcare.